![Dr. Ed Askew](https://cannabisindustryjournal.com/wp-content/uploads/2018/06/Ed-Askew_preview-80x52.png)
![Dr. Ed Askew](https://cannabisindustryjournal.com/wp-content/uploads/2018/06/Ed-Askew_preview.png)
After outlining the risks to address in quality plans earlier in the series, Dr. Askew shows how your brand can suffer in the court of public opinion.
After outlining the risks to address in quality plans earlier in the series, Dr. Askew shows how your brand can suffer in the court of public opinion.
Knowing the types of documents required for standards and regulations will help you stay ahead of compliance issues at your facility.
With an entire track dedicated to cannabis this year, attendees will learn about a range of critical issues connecting cannabis and food safety, from product safety to quality in edibles manufacturing to regulations and standards.
In late July, the first recall in the new regulatory environment was issued and days later, a different company issued another recall.
In Part 4, Dr. Askew explains matrix spikes and duplicate QC analyses for those looking to vet their lab partners
Vetting consultants properly and tracking progress on important projects can help you get the most out of your experience.
Smyth sat in a session on budtender training at last week’s NCIA Cannabis Business Summit and offers her summary of the events.
In Part 3, Dr. Askew dissects quality control results from labs and how a client could better understand them.
In Part 2, Dr. Askew takes a look at how potentially problematic laboratory cultures can affect test results.
This series of articles will help businesses better understand the laboratory jargon and their test results.